Earnings Scheduled For August 15, 2022
Companies Reporting Before The Bell
• Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.
JELD-WEN, Royal Caribbean Cruises And Some Other Big Stocks Moving Lower On Monday
FiscalNote Holdings Inc. (NYSE: NOTE) fell 22.7% to $6.43. FiscalNote closed its earlier-announced agreement to acquire Aicel Technologies.
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
Biophytis (NASDAQ:BPTS) stock moved upwards by 15.8% to $0.95 during Monday's after-market session. The company's market cap stands at $15.5 million.
The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics’ Tebipenem, Graybug Reviews Strategic Alternatives
Here's a roundup of top developments in the biotech space over the last 24 hours:
Roivant Sciences Q4 EPS $(0.39) Misses $(0.32) Estimate
Roivant Sciences (NASDAQ:ROIV) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.32) by 21.88 percent.
Earnings Scheduled For June 28, 2022
Companies Reporting Before The Bell
• Jupai Hldgs (NYSE:JP) is projected to report earnings for its first quarter.
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
Travere Therapeutics (NASDAQ:TVTX) stock increased by 16.5% to $28.87 during Friday's after-market session. The market value of their outstanding shares is at $1.8 billion.
Goldman Sachs Maintains Buy on Roivant Sciences, Lowers Price Target to $12
Goldman Sachs maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and lowers the price target from $15 to $12.
The Daily Biotech Pulse: INmune Bio’s Planned Alzheimer’s Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures
Here's a roundup of top developments in the biotech space over the last 24 hours:
